Adam Brockman Ph.D.

Adam Brockman PhD, DABT is a distinguished professional in the field of drug metabolism and pharmacokinetics (DMPK) with extensive experience spanning over two decades. Currently serving as Senior Director of DMPK at Jnana Therapeutics since October 2025, Adam previously held significant roles at Aldeyra Therapeutics, where responsibilities included overseeing translational science, DMPK, and non-clinical studies. Adam's expertise encompasses toxicology, pharmacology, and bioanalysis, developed through leadership positions at various biopharmaceutical firms including Cyprotex, Inotek Pharmaceuticals, and Merck. Adam earned a PhD in Biological Chemistry from The University of Georgia and a BS in Chemistry from the University of Pittsburgh.